The nasal spray is indicated for treating nasal symptoms of allergic rhinitis in patients ≥2 years, treating symptoms of nasal congestion from seasonal allergic rhinitis in patients ≥2 years, treating nasal polyps in patients ≥18 years, and prophylaxis of seasonal allergic rhinitis in patients ≥12 years. The inhaler is indicated for prophylaxis of asthma in patients ≥4 years. There are 3 formulations of mometasone furoate with various indications.
Metaz is a corticosteroid used to treat asthma, allergic rhinitis, nasal congestion, nasal polyps, dermatitis, and pruritus. Metaz diffuses across cell membranes to activate pathways responsible for reducing inflammation.
Metaz also has a lower affinity to mineralocorticoid receptors than natural corticosteroids, making it more selective in its action. Mometasone is a synthetic corticosteroid with an affinity for glucocorticoid receptors 22 times higher than that of dexamethasone. Metaz is formulated as a dry powder inhaler, nasal spray, and ointment for its different indications. It has a glucocorticoid receptor binding affinity 22 times stronger than dexamethasone and higher than many other corticosteroids as well.
MANULELITO C METAZ SKIN
Metaz is a corticosteroid drug that can be used for the treatment of asthma, rhinitis, and certain skin conditions.
0 kommentar(er)
